XPeng Inc ADR (XPEV) Testing Investors’ Patience Right Now

Currently, there are 767.65M common shares owned by the public and among those 758.37M shares have been available to trade.

The company’s stock has a 5-day price change of -16.88% and -43.74% over the past three months. XPEV shares are trading -47.36% year to date (YTD), with the 12-month market performance down to -25.07% lower. It has a 12-month low price of $7.51 and touched a high of $23.62 over the same period. XPEV has an average intraday trading volume of 13.58 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -18.10%, -15.83%, and -45.29% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of XPeng Inc ADR (NYSE: XPEV) shares accounts for 12.98% of the company’s 767.65M shares outstanding.

It has a market capitalization of $5.90B and a beta (3y monthly) value of 2.93. The earnings-per-share (ttm) stands at -$1.69. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.69% over the week and 5.38% over the month.

Analysts forecast that XPeng Inc ADR (XPEV) will achieve an EPS of -$0.31 for the current quarter, -$0.32 for the next quarter and -$0.7 for 2025. The lowest estimate earnings-per-share for the quarter is -$0.38 while analysts give the company a high EPS estimate of -$0.27. Comparatively, EPS for the current quarter was -$0.37 a year ago. Earnings per share for the fiscal year are expected to increase by 46.31%, and 41.79% over the next financial year. EPS should grow at an annualized rate of -5.74% over the next five years, compared to -33.39% over the past 5-year period.

Looking at the support for the XPEV, a number of firms have released research notes about the stock. BofA Securities stated their Buy rating for the stock in a research note on August 21, 2023, with the firm’s price target at $22. CLSA coverage for the XPeng Inc ADR (XPEV) stock in a research note released on August 08, 2023 offered a Buy rating with a price target of $24. HSBC Securities was of a view on August 07, 2023 that the stock is Buy, while UBS gave the stock Neutral rating on July 31, 2023, issuing a price target of $23. Macquarie on their part issued Outperform rating on July 27, 2023.

Most Popular

Related Posts